Liquid Chromatography–Mass Spectrometry in the Development of Natural Product–Based Antihypertensive Drugs: A Systematic Literature Review
DOI:
https://doi.org/10.58511/v3i2.9693Kata Kunci:
LC–MS, Natural Products, Antihypertensive, Metabolomics, Drug Development, Celery (Apium graveolens)Abstrak
Hypertension remains a major global health burden, necessitating effective and evidence-based therapeutic strategies. Natural products have emerged as promising sources of antihypertensive agents; however, their chemical complexity requires advanced analytical techniques such as liquid chromatography–mass spectrometry (LC–MS). This study employed a systematic literature review of articles published between 2020 and 2025, retrieved from Scopus, PubMed, and ScienceDirect using predefined inclusion criteria. The review evaluates the application of LC–MS in the identification, metabolite profiling, and standardization of antihypertensive natural products, with emphasis on celery (Apium graveolens). The findings indicate that LC–MS enables accurate identification of key bioactive compounds, including flavonoids, phenolic acids, alkaloids, and phthalides, which are associated with antihypertensive mechanisms such as angiotensin-converting enzyme (ACE) inhibition, vasodilation, and endothelial protection. Integration with pharmacological and in silico approaches further supports the correlation between chemical composition and biological activity. In conclusion, LC–MS is a critical tool in natural product-based antihypertensive drug discovery, particularly for compound characterization and standardization. However, lack of standardized workflows remains a limitation for reproducibility and clinical translation.
Referensi
[1] World Health Organization. Hypertension. Geneva: World Health Organization; 2023.
[2] Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi:10.1038/s41581-019-0244-2.
[3] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13–e115. doi:10.1161/HYP.0000000000000065.
[4] Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–1140. doi:10.1161/CIRCRESAHA.118.313220.
[5] Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.118.
[6] Bahramsoltani R, Rahimi R, Farzaei MH. Medicinal plants and their natural components as future drugs for hypertension. Pharmacol Res. 2017;130:246–259. doi:10.1016/j.phrs.2017.11.013.
[7] Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011;11(4):298–344.
[8] Niessen WMA. Liquid chromatography–mass spectrometry. 3rd ed. Boca Raton: CRC Press; 2017.
[9] Wolfender JL, Nuzillard JM, van der Hooft JJJ, et al. Accelerating metabolite identification in natural product research: toward an ideal combination of LC–HRMS and NMR profiling. Anal Chem. 2019;91(1):704–742. doi:10.1021/acs.analchem.8b05112.
[10] Dunn WB, Ellis DI. Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics. 2011;7(1):4–16. doi:10.1007/s11306-010-0210-8.
[11] Theodoridis G, Gika HG, Want EJ, Wilson ID. LC–MS-based global metabolite profiling: a review. Nat Protoc. 2016;11(9):1637–1657. doi:10.1038/nprot.2016.098.
[12] Kim HK, Verpoorte R. Sample preparation for plant metabolomics. Phytochem Anal. 2015;26(4):215–224. doi:10.1002/pca.2556.
[13] Wang M, Carver JJ, Phelan VV, et al. Sharing and community curation of mass spectrometry data with GNPS. Nat Biotechnol. 2016;34(8):828–837. doi:10.1038/nbt.3597.
[14] Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473–484. doi:10.1038/nrd.2016.32.
[15] Rinschen MM, Giera M, Siuzdak G. Identification of bioactive metabolites using metabolomics. Nat Rev Mol Cell Biol. 2019;20(6):353–367. doi:10.1038/s41580-019-0108-4.
[16] Scalbert A, Brennan L, Manach C, et al. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014;99(6):1286–1308. doi:10.3945/ajcn.113.076133.
[17] Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2017;36(1):1–24. doi:10.1002/mas.21492.
[18] Liu X, Wu D, Zhang Y, et al. LC–MS-based metabolomics in antihypertensive herbal medicine research. J Chromatogr B. 2018;1092:256–264. doi:10.1016/j.jchromb.2018.06.031.
[19] Zhang Y, Li X, Wang Z. Natural products targeting the renin–angiotensin system for hypertension therapy. Front Pharmacol. 2020;11:604. doi:10.3389/fphar.2020.00604.
[20] Pan SY, Litscher G, Gao SH, et al. New perspectives on Chinese herbal medicine research and development. Evid Based Complement Alternat Med. 2020;2020:124641. doi:10.1155/2020/124641.
[21] Chen J, Wang Y, Wu Y, et al. Apigenin as a natural angiotensin-converting enzyme inhibitor. Phytomedicine. 2020;69:153197. doi:10.1016/j.phymed.2020.153197.
[22] Saleh RM, Abou-El-Hassan A, El-Naggar ME. Antihypertensive activity of Apium graveolens L. J Ethnopharmacol. 2021;268:113575. doi:10.1016/j.jep.2020.113575.
[23] Sowbhagya HB. Chemistry, technology, and nutraceutical functions of celery (Apium graveolens L.). Crit Rev Food Sci Nutr. 2014;54(3):389–398. doi:10.1080/10408398.2011.586363.
[24] Zhou Y, Zheng J, Li Y, et al. Dietary polyphenols and blood pressure regulation. Nutrients. 2021;13(3):987. doi:10.3390/nu13030987.
[25] Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455(7216):1054–1056. doi:10.1038/4551054a.
[26] van der Greef J, Hankemeier T, McBurney RN. Metabolomics-based systems biology and personalized medicine. Pharmacogenomics. 2006;7(7):1087–1094. doi:10.2217/14622416.7.7.1087.
[27] Cajka T, Fiehn O. Comprehensive lipidomics by LC–MS. TrAC Trends Anal Chem. 2014;61:192–206. doi:10.1016/j.trac.2014.04.017.
[28] Blaženović I, Kind T, Ji J, Fiehn O. Software tools for metabolomics data analysis. Metabolites. 2018;8(2):31. doi:10.3390/metabo8020031.
[29] Xia J, Wishart DS. Using MetaboAnalyst for metabolomics data analysis. Curr Protoc Bioinformatics. 2016;55:14.10.1–14.10.91. doi:10.1002/cpbi.11.
[30] Wolfender JL, Rudaz S, Choi YH, Kim HK. Plant metabolomics: from holistic data to relevant biomarkers. Curr Med Chem. 2016;23(30):3313–3334. doi:10.2174/0929867323666160623111954
